Introducing Whole Genome Sequencing into Routine Healthcare: The 100,000 Genomes Project and Beyond
Dr Clare Turnbull is the Clinical Lead for Cancer Genomics for the Genomics England 100,000 Genomes Project. She will speak about this world-leading NHS transformation project through which whole genome sequencing is being introduced into clinical care across the UK for cancer and rare disease. She will focus on some of the challenging aspects of delivering the programme, such as (i) optimising pathology pipelines through routine healthcare for cancer sample collection and preparation (ii) interpretation of germline and tumour genomic data for clinical reporting and (iii) engagement of the UK clinical academic community into the program to optimise patient recruitment and research outputs
Clare also leads a research team at Institute of Cancer Research/Queen Mary University of London, undertaking translational studies in cancer genomics and genetic predisposition, with particular focus on the genetic basis of testicular cancer. Having trained as a Clinical Geneticist, her clinical work at Guys Hospital NHS Trust focuses on managing patients and families with genetic susceptibility to cancer.
Date: 16 March 2017, 11:00 (Thursday, 9th week, Hilary 2017)
Venue: NDM Building, Headington OX3 7FZ
Venue Details: TDI, Basement Seminar Room
Speaker: Dr Clare Turnbull (The Institute of Cancer Research)
Organising department: Ludwig Institute for Cancer Research, Oxford Branch
Organiser: Mary Muers (Oxford Ludwig Institute, NDM Experimental Medicine)
Organiser contact email address:
Host: Dr Gareth Bond (Ludwig Cancer Research, University of Oxford)
Part of: Ludwig Institute Seminar Series
Booking required?: Not required
Audience: Members of the University only
Editor: Mary Muers